Arsenic Trioxide

nuclear factor kappa B subunit 1 ; Homo sapiens







36 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35291620 Blockade of Nuclear Factor-Κb (NF-Κb) Pathway Using Bay 11-7082 Enhances Arsenic Trioxide-Induced Antiproliferative Activity in U87 Glioblastoma Cells. 2022 Jan 6
2 34303041 Arsenic trioxide induces expression of BCL-2 expression via NF-κB and p38 MAPK signaling pathways in BEAS-2B cells during apoptosis. 2021 Oct 1 1
3 31759055 De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties. 2020 Jan 15 2
4 32553459 c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis. 2020 Oct 1
5 32645343 Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway. 2020 Sep 15 3
6 30612216 Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells. 2019 Aug 2
7 29274627 Regulation of ABCG2 by nuclear factor kappa B affects the sensitivity of human lung adenocarcinoma A549 cells to arsenic trioxide. 2018 Jan 5
8 29574283 VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia. 2018 Jun 3
9 30145367 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant. 2018 Oct 1
10 30572915 Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loop. 2018 Dec 20 1
11 26276563 Arsenic Trioxide Attenuates NF-κB and Cytokine mRNA Levels in the Livers of Cocks. 2016 Apr 2
12 27039805 Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism. 2016 7
13 25395240 Up-regulation of miR-21 and miR-23a Contributes to As2 O3 -induced hERG Channel Deficiency. 2015 Jun 2
14 25845556 Tetraarsenic hexoxide demonstrates anticancer activity at least in part through suppression of NF-κB activity in SW620 human colon cancer cells. 2015 Jun 5
15 25972196 The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells. 2015 Jun 8
16 24627159 Arsenic hexoxide enhances TNF-α-induced anticancer effects by inhibiting NF-κB activity at a safe dose in MCF-7 human breast cancer cells. 2014 May 7
17 25047463 Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer. 2014 Dec 4
18 25196641 Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. 2014 Nov 18 2
19 22949821 Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. 2012 1
20 23387208 [Arsenic trioxide enhances TRAIL inducing human lung cancer cell line A549 cells apoptosis by down-regulate the expression of NF-kappaB]. 2012 Nov 5
21 20501519 Interaction between arsenic trioxide (ATO) and human neutrophils. 2011 May 2
22 19763917 Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin. 2010 Sep 4
23 20594187 Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies. 2010 Nov 1
24 18536579 NF-kappaB in the pathogenesis and treatment of multiple myeloma. 2008 Jul 1
25 17959082 [A study on the apoptosis of gastric carcinoma cells induced by arsenic trioxide combined with Ad-IkappaBalphaM]. 2007 Jul 1
26 16646077 Clinically tolerable concentrations of arsenic trioxide induce p53-independent cell death and repress NF-kappa B activation in Ewing sarcoma cells. 2006 Oct 1 2
27 17384263 Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells. 2006 Dec 5
28 15316930 Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 2005 Feb 2
29 15547942 Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. 2005 Mar 1 2
30 15949266 [Effects of dexamethasone on arsenic trioxide induced apoptosis, NF-kappaB activation and gene expression in lymphoma cell line]. 2005 Apr 3
31 16105982 NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs). 2005 Dec 1 3
32 16277838 [Arsenic trioxide induced leukemic cell apoptosis relative to NF-kappaB activation]. 2005 Oct 4
33 15202509 Dicoumarol alters cellular redox state and inhibits nuclear factor kappa B to enhance arsenic trioxide-induced apoptosis. 2004 Mar 1
34 15476326 [Relationship between drug resistance and the expression of NF-kappaB induced in leukemic cells]. 2004 Sep 4
35 11150309 Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. 2001 Apr 6 1
36 10448126 Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. 1999 Aug 15 2